SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,403,000 | +197.9% | 148,502 | +182.7% | 0.09% | +172.7% |
| Q2 2020 | $471,000 | +375.8% | 52,527 | +405.5% | 0.03% | +371.4% |
| Q1 2019 | $99,000 | -88.4% | 10,392 | -86.1% | 0.01% | -87.0% |
| Q4 2018 | $857,000 | +62.0% | 74,673 | +168.0% | 0.05% | +45.9% |
| Q1 2018 | $529,000 | +25.1% | 27,862 | +8.0% | 0.04% | -19.6% |
| Q4 2017 | $423,000 | -41.7% | 25,790 | -68.7% | 0.05% | -76.9% |
| Q2 2017 | $726,000 | +881.1% | 82,478 | +417.0% | 0.20% | +1070.6% |
| Q3 2016 | $74,000 | -66.7% | 15,952 | -56.5% | 0.02% | -34.6% |
| Q1 2016 | $222,000 | -60.8% | 36,687 | +1.6% | 0.03% | -55.2% |
| Q1 2015 | $566,000 | -55.7% | 36,100 | -57.0% | 0.06% | -74.3% |
| Q4 2014 | $1,277,000 | – | 83,958 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |